KOD Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
67.1M
+0.4%
66.8M
+11.8%
59.8M
+4.0%
57.5M
-7.9%
62.4M
R&D
58.3M
+4.0%
56.1M
+15.5%
48.5M
+6.7%
45.5M
-9.9%
50.5M
SG&A
8.8M
-18.2%
10.8M
-4.2%
11.2M
-6.1%
12.0M
+0.7%
11.9M
Operating Income
-67098000
-0.4%
-66838000
-11.8%
-59777000
-4.0%
-57453000
+7.9%
-62352000
EBITDA
-63006000
-0.4%
-62726000
-12.7%
-55668000
-5.2%
-52909000
+8.4%
-57765000
Net Income
-66223000
-0.9%
-65643000
-12.9%
-58158000
-2.5%
-56736000
+7.7%
-61457000
EPS (Basic)
$-1.05
+0.0%
$-1.05
-11.7%
$-0.94
+9.6%
$-1.04
+10.3%
$-1.16
EPS (Diluted)
$-1.05
+0.0%
$-1.05
-11.7%
$-0.94
+9.6%
$-1.04
+10.3%
$-1.16
Shares (Diluted)
63.0M
+0.5%
62.6M
+1.2%
61.9M
+13.6%
54.4M
+3.0%
52.9M
Kodiak Sciences (KOD) — Financials